Pancreatitis Trial, Recruiting NCT06113419 Sponsor: Hospital Universitario Mayor Méderi Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT06113419
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with pancreatitis (inflammation of the pancreas) that is classified as moderately severe or severe based on a standard medical score measured at the time you were admitted to hospital
  • Your pancreatitis has been confirmed through imaging (such as ultrasound, MRI, or CT scan) to be caused by gallstones or a problem with the bile duct
  • You have started to recover from your pancreatitis, meaning you have been able to eat and drink for at least 24 hours without vomiting and your pain is at a manageable level (4 out of 10 or less on a pain scale)
  • You are willing and able to give written consent to take part in the trial

Who may not be able to join:

  • You are currently pregnant
  • You have already had your gallbladder removed in the past
  • You are already scheduled to have your gallbladder removed through open (non-keyhole) surgery
  • You have developed serious complications from your pancreatitis before having keyhole gallbladder surgery, such as internal bleeding, a buildup of pressure in the abdomen, or a fluid collection around the pancreas that needed draining
  • You have been diagnosed with long-term (chronic) pancreatitis
  • You have had more than one episode of pancreatitis in the past
  • You currently have an active cancer diagnosis
  • You are experiencing septic shock (a life-threatening response to infection)
  • You have a gallstone stuck in your bile duct that could not be cleared by a procedure called ERCP, or you experienced a tear or pancreatitis as a result of that procedure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Camilo Ramirez-Giraldo, MD, Hospital Universitario Mayor Méderi

Phone: +5773206770474

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Universitario Mayor Méderi
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇴 Colombia

Primary endpoints

Major complications (rates); Major complications (rates); Major complications (rates)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov